Timothy E Corcoran

Title: Innovations in Lung Disease Treatment by Timothy E. Corcoran

Introduction

Timothy E. Corcoran is an accomplished inventor based in Pittsburgh, PA. He has made significant contributions to the field of medical research, particularly in the treatment of lung diseases. With a total of 2 patents, his work focuses on innovative therapies that harness the potential of cell-based treatments.

Latest Patents

Corcoran's latest patents include the development of red blood cell membrane-derived microparticles (RBC MPs) for the treatment of various lung diseases. These microparticles are designed to be depleted of hemoglobin and express phosphatidylserine on their surface. The administration of RBC MPs via inhalation promotes the production of immunoregulatory cytokines, such as IL-10, which helps reduce inflammation and injury in the lung. This innovative approach shows considerable potential as an immunomodulatory strategy for conditions like chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis.

Career Highlights

Corcoran is affiliated with the University of Pittsburgh, where he conducts his research and develops his inventions. His work has garnered attention for its potential to transform treatment options for patients suffering from debilitating lung conditions.

Collaborations

Some of his notable coworkers include Janet S. Lee and Valerian Kagan, who contribute to the collaborative efforts in advancing research in this vital area of healthcare.

Conclusion

Timothy E. Corcoran's innovative work in developing red blood cell membrane-derived microparticles represents a significant advancement in the treatment of lung diseases. His contributions continue to pave the way for new therapeutic strategies that could improve patient outcomes.